Gene · 156
Papers3,264
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,264
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| G protein-coupled receptor kinase 2 as a novel therapeutic target for gland fibrosis of Sjögren's syndrome. | Acta Pharmacol Sin | 2024 | 39054339 | PubTator, text mining | PubMed |
| Identification of exosomal microRNAs and related hub genes associated with imatinib resistance in chronic myeloid leukemia. | Naunyn Schmiedebergs Arch Pharmacol | 2024 | 38916832 | PubTator, text mining | PubMed |
| Screening of potential drugs for the treatment of diabetic kidney disease using single-cell transcriptome sequencing and connectivity map data. | Biochem Biophys Res Commun | 2024 | 38905995 | PubTator, text mining | PubMed |
| Biasing Gβγ Downstream Signaling with Gallein Inhibits Development of Morphine Tolerance and Potentiates Morphine-Induced Nociception in a Tolerant State. | Mol Pharmacol | 2024 | 38769020 | PubTator, text mining | PubMed |
| Graph neural networks-based prediction of drug gene association of P2X receptors in periodontal pain. | J Oral Biol Craniofac Res | 2024 | 38680473 | PubTator, text mining | PubMed |
| A novel GRK2 variant in a patient with Jeune asphyxiating thoracic dysplasia accompanied by Morgagni hernia. | Am J Med Genet A | 2024 | 38647386 | PubTator, text mining | PubMed |
| Reanalysis of Whole-Exome Sequencing Data of an Infant with Suspected Diagnosis of Jeune Syndrome Revealed a Likely Pathogenic Variant in GRK2: A Newly Associated Gene for Jeune Syndrome Phenotype. | Mol Syndromol | 2024 | 38585547 | PubTator, text mining | PubMed |
| Unveiling the therapeutic prospects of EGFR inhibition in rotenone-mediated parkinsonism in rats: Modulation of dopamine D3 receptor. | Brain Res | 2024 | 38554797 | PubTator, text mining | PubMed |
| Current perspectives and trend of computer-aided drug design: a review and bibliometric analysis. | Int J Surg | 2024 | 38502850 | PubTator, text mining | PubMed |
| The role of G protein-coupled receptor kinases in GLP-1R β-arrestin recruitment and internalisation. | Biochem Pharmacol | 2024 | 38461904 | PubTator, text mining | PubMed |
| Exploring the potential biological function of GRK2 in colorectal cancer. | Funct Integr Genomics | 2024 | 38446273 | PubTator, text mining | PubMed |
| Kinome and phosphoproteome reprogramming underlies the aberrant immune responses in critically ill COVID-19 patients. | Clin Proteomics | 2024 | 38389037 | PubTator, text mining | PubMed |
| GPCR kinases differentially modulate biased signaling downstream of CXCR3 depending on their subcellular localization. | Sci Signal | 2024 | 38349966 | PubTator, text mining | PubMed |
| Muscarinic acetylcholine receptor-mediated phosphorylation of extracellular signal-regulated kinase in HSY salivary ductal cells involves distinct signaling pathways. | J Oral Biosci | 2024 | 38336259 | PubTator, text mining | PubMed |
| GPR39 regulated spinal glycinergic inhibition and mechanical inflammatory pain. | Sci Adv | 2024 | 38306424 | PubTator, text mining | PubMed |
| Propranolol: a new pharmacologic approach to counter retinopathy of prematurity progression. | Front Pediatr | 2024 | 38292211 | PubTator, text mining | PubMed |
| GRK2 inhibits Flt-1+ macrophage infiltration and its proangiogenic properties in rheumatoid arthritis. | Acta Pharm Sin B | 2024 | 38261818 | PubTator, text mining | PubMed |
| From Synaptic Physiology to Synaptic Pathology: The Enigma of α-Synuclein. | Int J Mol Sci | 2024 | 38256059 | PubTator, text mining | PubMed |
| Obesity and Insulin Resistance in Asthma Pathogenesis and Clinical Outcomes. | Biomedicines | 2024 | 38255279 | PubTator, text mining | PubMed |
| MicroRNAs Associated with a Bad Prognosis in Acute Myeloid Leukemia and Their Impact on Macrophage Polarization. | Biomedicines | 2024 | 38255226 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/156/papers?page=6